help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reid, I. A.
Right arrow Articles by Keil, L. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reid, I. A.
Right arrow Articles by Keil, L. C.

Endocrinology, Vol 104, 1403-1406, Copyright © 1979 by Endocrine Society

ARTICLES

Suppression of vasopressin secretion by clonidine: effect of alpha- adrenoceptor antagonists

IA Reid, PL Nolan, JA Wolf and LC Keil

Studies were performed in anesthetized dogs to determine if the diuretic effect of clonidine results from inhibition of vasopressin secretion. Intravenous clonidine (30 microgram/kg) decreased plasma vasopressin concentration (as measured by RIA) from 10.9 +/- 1.5 to 5.0 +/- 1.1 ng/ml (P less than 0.01) in association with a transient increase in arterial blood pressure and a decrease in heart rate. Intravenous administration of two alpha-adrenoceptor antagonists, piperoxane and phentolamine, virtually abolished the pressor effect of clonidine but did not prevent the suppression of plasma vasopressin concentration. Clonidine decreased plasma vasopressin concentration from 11.9 +/- 3.1 to 3.3 +/- 1.0 pg/ml in the phentolamine-treated dogs (P less than 0.01) and from 18.1 +/- 4.5 to 12.4 +/- 3.6 pg/ml in the piperoxane-treated dogs (P less than 0.05). These results provide direct evidence that the diuretic effect of clonidine results from inhibition of the secretion of vasopressin. This inhibition does not appear to be a consequence of the pressor effect of the drug but may result from a direct action in the central nervous system.


This article has been cited by other articles:


Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
R. G. Menegaz, D. R. Kapusta, H. Mauad, and A. de Melo Cabral
Activation of {alpha}2-receptors in the rostral ventrolateral medulla evokes natriuresis by a renal nerve mechanism
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2001; 281(1): R98 - R107.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. D. M. Cabral, D. R. Kapusta, V. A. Kenigs, and K. J. Varner
Central alpha 2-receptor mechanisms contribute to enhanced renal responses during ketamine-xylazine anesthesia
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 1998; 275(6): R1867 - R1874.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
J. Parlow, J.-P. Viale, G. Annat, R. Hughson, and L. Quintin
Spontaneous Cardiac Baroreflex in Humans : Comparison With Drug-Induced Responses
Hypertension, May 1, 1995; 25(5): 1058 - 1068.
[Abstract] [Full Text]

Home page
 ScienceHome page
W. Blessing, A. Sved, and D. Reis
Destruction of noradrenergic neurons in rabbit brainstem elevates plasma vasopressin, causing hypertension
Science, August 13, 1982; 217(4560): 661 - 663.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1979 by The Endocrine Society